The FDA’s recent decisions regarding compound GLP-1s have had a significant impact on the obesity drug market, particularly for pharma…
Browsing: Obesity
Roche stood out because they had thought the most about how to lead in this space and we believed they…
AbbVie Ventures into Obesity Drug Development with Gubra Licensing Deal AbbVie recently made headlines by entering into a partnership with…
BioAge Labs is redirecting its focus back to aging research after a setback in the obesity field. The biotech company…
The body mass index (BMI) has long been a standard metric used to assess obesity levels, but a new report…
The obesity market has been a major player in the pharmaceutical industry in 2024, with GLP-1 medications from Novo Nordisk…
The pharmaceutical industry is gearing up for a busy 2025, with a focus on research and development to fill gaps…
Not all residents have access to safe drinking water. Credit: Department of Foreign Affairs and Trade, CC BY One in…
The Food and Drug Administration recently approved Eli Lilly’s obesity drug Zepbound, also known as tirzepatide, as the first treatment…
Obesity is a growing concern worldwide, with various racial and ethnic groups facing disparities in accessing obesity-management medications. A recent…
